🟢 Neumora Therapeutics is trading 6.99% up in pre-market as S&P 500 and Nasdaq Composite rise

Neumora Therapeutics is trading up 6.99% at $0.78 in pre-market as broader risk-on sentiment supports the move.

• S&P 500 is up 0.68%, while Nasdaq Composite is up 1.03% in a broadly stronger pre-market session.
• No fresh company-specific catalyst was identified for September 21, 2026. Recent NMRA-215 coverage concerned previously reported preclinical toxicology data, not a new announcement.